期刊文献+

慢性重型乙型肝炎晚期患者短期预后影响因素分析 被引量:7

Influential Factor of Short-term Prognosis in Advanced Stage Patients with Chronic Severe Hepatitis B
下载PDF
导出
摘要 目的探讨影响慢性重型乙型肝炎(CSHB)晚期患者近期死亡的因素。方法回顾性分析45例CSHB晚期患者入院当日资料,计算MELD、CTP评分,观察30 d内生存情况,单因素及多因素Logistic回归分析入院当日变量与近期预后之间的关系。结果31例患者30 d内死亡,病死率为68.9%(31/45),死亡原因主要为肝性脑病,占71.0%(22/31),其次为多器官功能衰竭综合征,为22.6%(7/31)。单因素分析显示入院时MELD评分与总胆红素水平是近期存活的预测因素,多因素Logistic回归分析示近期生存与总胆红素、CTP及MELD评分相关。血清学e抗原阴性与阳性、性别在近期生存组与死亡组的差异有统计学意义(分别P<0.01和<0.05)。结论男性、e抗原阴性、入院时总胆红素水平、肝性脑病及肝肾综合征是CSHB晚期患者近期死亡的高危因素;入院时的MELD及CTP评分均可评估其近期预后。 Objective To explore the influential factor of short-term prognosis in advanced stage patients with chronic severe hepatitis (CSH) B. Methods A retrospective chart review and statistical analysis were done on 45 patients consecutively admitted to CSHB. Results Thirty-one patients died during 30 days, mortality was 68.9%, hepatic encephalopathy (HE) was mainly cause of death (71.0%), next was multiorgan dysfunction syndrome(22.6%), admission MELD scores (P〈 0.05) and total bilirubin (P〈0.01) were independently associated with 30 days mortality, multiple factor Logistic regression analysis showed total bilirubin(P〈0.01), MELD scores(P〈0.05), and Child- Turcotte-Pugh(CTP) scores(P〈0.05) were associated with short-term mortality, e antigen and sexuality in short-term prognosis were significantly different (P〈0.05). Conclusion High risk factor of short- term in advanced stage CSH is negative e antigen, hepatitis B, male, TBIL, HE, hepatorenal syn- drome(HRS) on admission. MELD and CTP score on admission can be used to evaluate short-term prognosis.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2008年第3期433-435,共3页 Suzhou University Journal of Medical Science
关键词 慢性乙型重型肝炎 终末期肝病模型评分 预后 chronic severe hepatitis B MELD prognosis
  • 相关文献

参考文献8

  • 1F orman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD [J]. Hepatology, 2001, 33(2):473-475. 被引量:1
  • 2中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14014
  • 3甘建和,赵卫峰,徐杰,吴建成,罗二平,江敏华,陈祖涛,吴旭东,施敏.血浆置换量对重型肝炎治疗效果的影响[J].中华肝脏病杂志,2003,11(10):594-594. 被引量:5
  • 4Huo TI, Lin HC, Wu JC, et al. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis[J]. Liver Transpl,2006, 12(1):65-71. 被引量:1
  • 5Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th world congresses of gastroenterology, Vienna, 1998 [J]. Hepatology, 2002,35 ( 3 ) :716-721. 被引量:1
  • 6Chu C J, Keeffe EB, Han SH, et al. Prevalence of HBV precore/core promoter variants in the United States [J]. Hepatology, 2003,38 (3) :619-628. 被引量:1
  • 7张汉荣,刘新钰,孙梅,钟备,赵巍,曹利,李敏.慢性重型乙型肝炎患者的乙型肝炎病毒C基因启动子和前C基因变异及与e抗原系统的关系[J].江苏医药,2004,30(6):406-408. 被引量:8
  • 8Srikureja W, Kyulo NL, Runyon BA, et al. MELD score is a better prognostic model than Child-Turcotte-Pugh score or discriminant function score in patients with alcoholic hepatitis [J]. Journal of Hepatology,2005, 42(5):700-706. 被引量:1

二级参考文献6

  • 1Kondrup T, Almdal H, Vilatrup H, et al. High volume plasma exchange in fulminant hepatic failure. Int J Artif Organs, 1992, 15: 669. 被引量:1
  • 2Carman WF,Jacyna F,Hadziyannis S,et al.Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.Lancet,1989,2:588-590. 被引量:1
  • 3Okamoto H,Tsuda F,Akahane Y,et al.Hepatitis B virus with mutation in the core promoter for an eantigennegative phenotype in carriers with antibody to e antigen.J Virol,1994,68:8102-8110. 被引量:1
  • 4Hasegawa K,huang JK,Wands JR,et al.Association of hepatitis B viral precore mutations with fulminant hepatitis B in Japan.Virology,1991,185:460-463. 被引量:1
  • 5Chu CJ,Keeffe EB,Han SH,et al.Prevalence of HBV precore/core promoter variants in the united states.Hepatology,2002,29:1274-1276. 被引量:1
  • 6李聪智,谭德明,刘双虎,谢玉桃,罗向群,黄燕,刘翠梅.人工肝支持系统治疗重型肝炎的临床研究[J].湖南医科大学学报,2001,26(4):377-378. 被引量:20

共引文献14020

同被引文献83

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部